Delivery Order SPE2DB22D3501-SPE2DB25FXA21
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,567.64 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, with a contract ceiling value of $14,863.40. The award, issued on July 30, 2025, is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025. This non-competitive set-aside award represents a specific pharmaceutical procurement from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place...
- The Defense Logistics Agency awarded a delivery order valued at $11,704.73 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the company's larger pharmaceutical supply framework with the federal government. The product will be performed and delivered from AmerisourceBergen's facility in...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) for Orencia 125 mg/mL syringes valued at $8,646.31. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction processed through the company's existing Indefinite...
- The Defense Logistics Agency awarded a $5,590.59 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Orencia 125 mg/ml syringes. This competitively awarded, firm fixed-price contract is not set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be executed from the contractor's location in...
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Orencia 125 mg/ml syringes with a ceiling value of $8,140.49. This firm fixed-price delivery order represents a non-set-aside competitive award and is expected to be completed by July 23, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $26,329.73 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,402.97 firm-fixed-price delivery order is for the supply of Orencia 250 mg vials, with a completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orencia 125 mg/mL syringes, valued at $3,701.46. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXA21Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,427.94 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials. This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. No set-aside designation was applied to this award, demonstrating the contractor's capability to compete successfully in open federal procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a comprehensive global pharmaceutical support vehicle, this prime contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Orencia, a biologic immunosuppressant medication, supports the Defense Health Agency and other federal healthcare systems' medical supply chain requirements. The company's consistent track record of fulfilling federal pharmaceutical orders through firm fixed-price delivery orders positions it as a critical vendor within the DLA's medical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/25/25 |